# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 1.1.2

Extent: E+W+S+N.I.

Diamino pyrimidine derivatives
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Baquiloprim
Baquiloprim
Bovine
10 μg/kg
Fat
300 μg/kg
Liver
150 μg/kg
Kidney
30 μg/kg
Milk
Porcine
40 μg/kg
Skin and fat
50 μg/kg
Liver
50 μg/kg
Kidney
Trimethoprim
Trimethoprim
Bovine
50 μg/kg
Muscle
50 μg/kg
Fat
50 μg/kg
Liver
50 μg/kg
Kidney
50 μg/kg
Milk
Porcine
50 μg/kg
Muscle
50 μg/kg
Skin and fat
50 μg/kg
Liver
50 μg/kg
Kidney
Equidae
100 μg/kg
Muscle
100 μg/kg
Fat
100 μg/kg
Liver
100 μg/kg
Kidney
Poultry
50 μg/kg
Muscle
Not for use in animals from which eggs are produced for human consumption
50 μg/kg
Skin and fat
50 μg/kg
Liver
50 μg/kg
Kidney
Fin fish
50 μg/kg
Muscle and skin in natural proportions

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/I/division/1/division/1.1/division/1.1.2 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-I/division-1/division-1.1/division-1.1.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.